$3.99
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Atea Pharmaceuticals (AVIR) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAtea Pharmaceuticals (NASDAQ:AVIR) Stock Quotes, Forecast and News Summary
Atea Pharmaceuticals Stock (NASDAQ: AVIR) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 235.75K |
| Day Range | - - - |
| 52 Wk Range | 2.77 - 4.60 |
| Market Cap | $336.84M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 62 |
| Short Interest | 4.7% |
| Days to Cover | 12.96 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Atea Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, devel...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Atea Pharmaceuticals (AVIR) stock?
You can purchase shares of Atea Pharmaceuticals (NASDAQ:AVIR) through any online brokerage.
Who are Atea Pharmaceuticals (AVIR) competitors?
Other companies in Atea Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for Atea Pharmaceuticals (AVIR) stock?
Atea Pharmaceuticals has a consensus price target of $6.44.
What is the current price for Atea Pharmaceuticals (AVIR)?
The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $3.99 last updated September 18, 2024 at 4:00 PM EDT.
Does Atea Pharmaceuticals (AVIR) pay a dividend?
There are no upcoming dividends for Atea Pharmaceuticals.
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
Atea Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Atea Pharmaceuticals (AVIR) going to split?
There is no upcoming split for Atea Pharmaceuticals.
What sector and industry does Atea Pharmaceuticals (AVIR) operate in?
Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.